Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Hens

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
International Journal of Pharmaceutics|June 22, 2026
From simplicity to complexity: how excipients shape stability and disintegration of immediate-release tabletsIsra Ibrahim, James Mann, Fredrik Winge, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 28, 2014
Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive toolsBart Hens, Joachim Brouwers, Bart Anneveld, et al.
The AAPS Journal|June 8, 2019
"Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development StrategyBart Hens, Maura Corsetti, Marival Bermejo, et al.
British Journal of Clinical Pharmacology|July 2, 2016
Drug disposition before and after gastric bypass: fenofibrate and posaconazoleIna Gesquiere, Bart Hens, Bart Van der Schueren, et al.
Molecular Pharmaceutics|August 18, 2017
In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of PosaconazoleBart Hens, Shriram M Pathak, Amitava Mitra, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2024
Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinibAlessia Favaron, Bart Hens, Maiara Camotti Montanha, et al.
Molecular Pharmaceutics|October 27, 2018
Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate-CO<sub>2</sub> Buffer in a Phase-Heterogenous System: Physiological and Pharmaceutical SignificanceJozef Al-Gousous, Kathy X Sun, Daniel P McNamara, et al.
Pharmaceutics|April 30, 2021
An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib ProductsIsabel Gonzalez-Alvarez, Marival Bermejo, Yasuhiro Tsume, et al.
The AAPS Journal|November 13, 2019
Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug DissolutionAlex Yu, Mark J Koenigsknecht, Bart Hens, et al.
Molecular Pharmaceutics|February 20, 2026
An Expert's View on the Application of TIM Technology in the Development of Oral Drug ProductsÁlvaro López Mármol, Richard Barker, Mirko Koziolek, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
International Journal of Pharmaceutics|June 22, 2026
From simplicity to complexity: how excipients shape stability and disintegration of immediate-release tabletsIsra Ibrahim, James Mann, Fredrik Winge, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 28, 2014
Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive toolsBart Hens, Joachim Brouwers, Bart Anneveld, et al.
The AAPS Journal|June 8, 2019
"Development of Fixed Dose Combination Products" Workshop Report: Considerations of Gastrointestinal Physiology and Overall Development StrategyBart Hens, Maura Corsetti, Marival Bermejo, et al.
British Journal of Clinical Pharmacology|July 2, 2016
Drug disposition before and after gastric bypass: fenofibrate and posaconazoleIna Gesquiere, Bart Hens, Bart Van der Schueren, et al.
Molecular Pharmaceutics|August 18, 2017
In Silico Modeling Approach for the Evaluation of Gastrointestinal Dissolution, Supersaturation, and Precipitation of PosaconazoleBart Hens, Shriram M Pathak, Amitava Mitra, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2024
Can in vitro/in silico tools improve colonic concentration estimations for oral extended-release formulations? A case study with upadacitinibAlessia Favaron, Bart Hens, Maiara Camotti Montanha, et al.
Molecular Pharmaceutics|October 27, 2018
Mass Transport Analysis of the Enhanced Buffer Capacity of the Bicarbonate-CO<sub>2</sub> Buffer in a Phase-Heterogenous System: Physiological and Pharmaceutical SignificanceJozef Al-Gousous, Kathy X Sun, Daniel P McNamara, et al.
Pharmaceutics|April 30, 2021
An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib ProductsIsabel Gonzalez-Alvarez, Marival Bermejo, Yasuhiro Tsume, et al.
The AAPS Journal|November 13, 2019
Mechanistic Deconvolution of Oral Absorption Model with Dynamic Gastrointestinal Fluid to Predict Regional Rate and Extent of GI Drug DissolutionAlex Yu, Mark J Koenigsknecht, Bart Hens, et al.
Molecular Pharmaceutics|February 20, 2026
An Expert's View on the Application of TIM Technology in the Development of Oral Drug ProductsÁlvaro López Mármol, Richard Barker, Mirko Koziolek, et al.
Pageof 6